Studied in hepatitis, immune support, and as an adjuvant; approved in several countries, not FDA-approved.
Thymosin alpha-1 is a small fragment of a larger natural protein that helps tune the immune system. Rather than killing pathogens directly, it acts as a modulator — adjusting how immune cells respond.
It influences the maturation and signaling of T cells and dendritic cells and interacts with pattern-recognition (Toll-like) receptors, nudging the immune response toward a more active, balanced state. This is why it's been studied as an add-on in chronic viral infections like hepatitis and as an adjuvant in some cancer settings.
It's approved in several countries and given by injection, but it isn't FDA-approved, and trial results across its proposed uses have been mixed rather than definitive.
Searching the published record…
Searching the published record…
Searching the published record…
Studies are surfaced live from the U.S. National Library of Medicine (PubMed). biohackr indexes and links the published record; it does not host or alter source articles.